The role of human papillomavirus infection in prostate carcinoma

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 1, 2010, Pages 64-69

  Aghakhani, Arezoo ^a   Hamkar, Rasool ^b   Parvin, Mahmoud ^c   Ghavami, Nastaran ^d   Nadri, Mahsa ^d   Pakfetrat, Attesa ^e   Banifazl, Mohammad ^f   Eslamifar, Ali ^a   Izadi, Nabiollah ^g   Jam, Sara ^h   Ramezani, Amitis ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f Iranian Society for Support of Patients with Infectious Diseases   (Iran)

^g IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^h TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PROSTATE CARCINOMA; RISK FACTOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DNA PRIMERS; DNA, VIRAL; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, MOLECULAR; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS;

EID: 78650262918     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.502904     Document Type: Article

References (44)

1. Hosseini SY , Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR, et al. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mLundergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol 2007;33:167-73.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8): S4-66.
3. Strickler HD, Burk R, Shah K, Viscidi R, Jackson A, Pizza G, et al. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998;82:1118-25.
4. Zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
5. Key T. Risk factors for prostate cancer. Cancer Surv 1995; 23:63-77.
6. IARC Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Volume 64. Lyon, France: IARC; 1995.
7. Bosch FX, Manos MM, Muñ oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study group. J Natl Cancer Inst (Bethesda) 1995;87:779-80.
8. Nelson WG, DeMarzo AM, DeWeese TL. The molecular pathogenesis of prostate cancer: focus on the earliest steps. Eur Urol 2001;39(Suppl 4):8-11.
9. McNicol PJ, Dodd JG. Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplifi cation assay. J Clin Microbiol 1990;28:409-12.
10. McNicol PJ, Dodd JG. Detection of papillomavirus DNA in human prostatic tissue by Southern blot analysis. Can J Microbiol 1990;36:359-62.
11. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res1992;52:5991-6.
12. Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD. Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate 1993;22:171-80.
13. Dodd JG, Paraskevas M, McNicol PJ. Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 1993;149:400-2.
14. Al Moustafa AE. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 2008;71:209-11.
15. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiological evidence showing that humanpapillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
16. Far AE, Aghakhani A, Hamkar R, Ramezani A, Pishbigar HF, Mirmomen S, et al. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis 2007;39:58-62.
17. Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, et al. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 1992;148:1822-6.
18. Tu H, Jacobs SC, Mergner WJ, Kyprianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 1994;44: 726-31.
19. Moyret-Lalle C, Mar ais C, Jacquemier J, Moles JP, Daver A, Soret JY, et al. ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 1995;64:124-9.
20. Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J. Detection of human papillomavirus DNA and p53 mutations in human prostate cancer. Prostate 1996;28:318-24
21. Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, et al. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 1996;28:117-23.
22. Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:763-8.
23. Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 2004;19:257-61.
24. Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, et al. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14:2952-5.
25. Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005;5:15.
26. Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos DA. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 2007;22:245-51.
27. McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. J Urol 1991;145:850-3.
28. Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N. Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 1991; 84:235-6.
29. Effert PJ, Frye RA, Neubauer A, Liu ET, Walther PJ. Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J Urol 1992;147:192-6.
30. Serfl ing U, Ciancio G, Zhu WY, Leonardi C, Penneys NS. Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostate tissue using the polymerase chain reaction. J Urol 1992;148:192-4.
31. Gherdovich S, Barbacci P, Mitrione MP, Farina U, Muraro GB, Anichini M. Detection of the human papillomavirus in hyperplastic and cancerous prostatic tissue with PCR. Minerva Urol Nefrol 1997;49:73-7.
32. Saad F, Gu K, Jean-Baptiste J, Gauthier J, MesMasson AM. Absence of human papillomavirus sequences in early stage prostate cancer. Can J Urol 1999;6:834-8.
33. Gazzaz FS, Mosli HA. Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 2009;30:633-7.
34. Bergh J, Marklund I, Gustavsson C, Wiklund F, Gr n berg H, Allard A, et al. No link between viral fi ndings in the prostate and subsequent cancer development. Br J Cancer 2007; 96:137-9.
35. Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 1998;26:165-9.
36. Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 1999;59:823-5.
37. Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. JAMA. 2000;283:340-1.
38. Adami HO, Kuper H, Andersson SO, Bergstr m R, Dillner J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2003;12: 872-5.
39. Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 1998;75:564-7.
40. Cuzick J. Human papillomavirus infection of the prostate. Cancer Surv 1995;23:91-5.
41. Grussendorf-Conen E, Deutz FJ, de Villiers EM. Detection of human papillomavirus-6 in primary carcinoma of the urethra in men. Cancer 1987;60:1832-5.
42. Scholefi eld JH, Hickson WG, Smith JH, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;340:1271-3.
43. Kong DB, Zheng XY, Xie LP, Sima N. Is prostate cancer an HPV-associated lesion? Med Hypotheses 2009;72:101.
44. Kuczyk M, Serth J, Machtens S, Jonas U. Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis. Prostate Cancer Prostatic Dis 2000;3(S1):S23.